Search

Your search keyword '"Tripepi, Giovanni"' showing total 1,976 results
Start Over Author "Tripepi, Giovanni"
1,976 results on '"Tripepi, Giovanni"'

1. Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes or heart failure

Author

Wang, Yi, Ciampi, Quirino, Cortigiani, Lauro, Zagatina, Angela, Kasprzak, Jaroslaw D., Wierzbowska-Drabik, Karina, Haberka, Maciej, Lowenstein, Jorge, Arbucci, Rosina, Haber, Diego M. Lowenstein, Marconi, Sofia, Merlo, Pablo M., Barral, Patricia, Souto, Germán, Djordjevic-Dikic, Ana, Reisenhofer, Barbara, Boshchenko, Alla, Ryabova, Tamara, Rodriguez-Zanella, Hugo, Rigo, Fausto, D’Andrea, Antonello, Gaibazzi, Nicola, Merli, Elisa, Lisi, Matteo, Simova, Iana, Barbieri, Andrea, Morrone, Doralisa, Pitino, Annalisa, De Nes, Michele, Tripepi, Giovanni L., Yin, Lixue, Citro, Rodolfo, Carerj, Scipione, Pepi, Mauro, Pellikka, Patricia A., and Picano, Eugenio

Published
2024
Full Text
View/download PDF

5. Retrospective ANalysis of multi-drug resistant Gram-nEgative bacteRia on veno-venous extracorporeal membrane oxygenation. The multicenter RANGER STUDY

Author

Boscolo, Annalisa, Bruni, Andrea, Giani, Marco, Garofalo, Eugenio, Sella, Nicolò, Pettenuzzo, Tommaso, Bombino, Michela, Palcani, Matteo, Rezoagli, Emanuele, Pozzi, Matteo, Falcioni, Elena, Pistollato, Elisa, Biamonte, Eugenio, Murgolo, Francesco, D’Arrigo, Graziella, Gori, Mercedes, Tripepi, Giovanni Luigi, Gottin, Leonardo, Longhini, Federico, Grasso, Salvatore, Navalesi, Paolo, and Foti, Giuseppe

Published
2024
Full Text
View/download PDF

10. Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients

Author

Liberale, Luca, Torino, Claudia, Pizzini, Patrizia, Mezzatesta, Sabrina, D'Arrigo, Graziella, Gori, Mercedes, Carbone, Federico, Schiavetta, Elisa, Cugno, Valeria, Cabri, Mara, Sgura, Cosimo, Maioli, Elia, Mbarga, Danielle, Rubini, Gianluca, Tirandi, Amedeo, Ramoni, Davide, Mallamaci, Francesca, Tripepi, Giovanni, Zoccali, Carmine, and Montecucco, Fabrizio

Published
2024
Full Text
View/download PDF

11. Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

Author

Chiricozzi, Andrea, Ortoncelli, Michela, Schena, Donatella, Gori, Niccolò, Ferrucci, Silvia Mariel, Babino, Graziella, Napolitano, Maddalena, Fargnoli, Maria Concetta, Stingeni, Luca, Rossi, Mariateresa, Romanelli, Marco, Balestri, Riccardo, Pellegrino, Michele, Parodi, Aurora, Bertoldi, Alberto Maria, Palazzo, Giovanni, Antonelli, Flaminia, Pitino, Annalisa, Tripepi, Giovanni, Fabbrocini, Gabriella, Balato, Anna, Marzano, Angelo Valerio, Girolomoni, Giampiero, Ribero, Simone, and Peris, Ketty

Published
2023
Full Text
View/download PDF

15. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation

Author

Martino, Massimo, Gori, Mercedes, Porto, Gaetana, Pellicano, Maria, Santoro, Ludovica, Verduci, Chiara, Canale, Filippo Antonio, Loteta, Barbara, Moscato, Tiziana, Alati, Caterina, Ieracitano, Maria Consuelo, Cuzzocrea, Amelia, Altomonte, Maria, Florenzano, Maria Teresa, Morabito, Antonella, Irrera, Giuseppe, Naso, Virginia, Pugliese, Marta, Console, Giuseppe, Ferreri, Anna, Imbalzano, Lucrezia, Tripepi, Giovanni, and Pitino, Annalisa

Published
2023
Full Text
View/download PDF

18. Leadless pacemakers in patients with different stages of chronic kidney disease: Real-world data from the updated i-LEAPER registry

Author

Mitacchione, Gianfranco, Schiavone, Marco, Gasperetti, Alessio, Tripepi, Giovanni L., Cerini, Manuel, Montemerlo, Elisabetta, Del Monte, Alvise, Bontempi, Luca, Moltrasio, Massimo, Breitenstein, Alexander, Monaco, Cinzia, Palmisano, Pietro, Rovaris, Giovanni, Chierchia, Gian-Battista, Dello Russo, Antonio, Biffi, Mauro, de Asmundis, Carlo, Mazzone, Patrizio, Di Biase, Luigi, Gallieni, Maurizio, Tondo, Claudio, Curnis, Antonio, and Forleo, Giovanni B.

Published
2024
Full Text
View/download PDF

21. Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

Author

Chiricozzi, Andrea, Ortoncelli, Michela, Schena, Donatella, Gori, Niccolò, Ferrucci, Silvia Mariel, Babino, Graziella, Napolitano, Maddalena, Fargnoli, Maria Concetta, Stingeni, Luca, Rossi, Mariateresa, Romanelli, Marco, Balestri, Riccardo, Pellegrino, Michele, Parodi, Aurora, Bertoldi, Alberto Maria, Palazzo, Giovanni, Antonelli, Flaminia, Pitino, Annalisa, Tripepi, Giovanni, Fabbrocini, Gabriella, Balato, Anna, Marzano, Angelo Valerio, Girolomoni, Giampiero, Ribero, Simone, and Peris, Ketty

Published
2023
Full Text
View/download PDF

23. P0831HIGH SERUM ALKALINE PHOSPHATASE PREDICTS THE RISK OF CKD PROGRESSION: EFFECT NODIFICATION BY THE GFR

Author

Mallamaci, Francesca, D'arrigo, Graziella, Marino, F, Caridi, Graziella, Parlongo, Giovanna, Leonardis, Daniela, Pizzini, Patrizia, Cutrupi, Sebastiano, Pisano, Anna, Tripepi, Giovanni Luigi, Kalantar-Zadeh, Kamyar, and Zoccali, Carmine

Subjects
Cardiovascular, Prevention, Kidney Disease, Clinical Research, Renal and urogenital, Clinical Sciences, Urology & Nephrology
Abstract

Abstract Background and Aims In the post-hoc analyses of the SUSTAIN and ASSURE trials (Kidney Blood Press Res. 2018;43:449-457), Apabetalone, an epigenetic modulator which lowers serum alkaline phosphatase (AlkPhos), stabilized the GFR in patients with cardiovascular disease and a GFR

Published
2020

26. Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes or heart failure

Author

Wang, Yi, primary, Ciampi, Quirino, additional, Cortigiani, Lauro, additional, Zagatina, Angela, additional, Kasprzak, Jaroslaw D., additional, Wierzbowska-Drabik, Karina, additional, Haberka, Maciej, additional, Barral, Patricia, additional, Souto, Germán, additional, Djordjevic-Dikic, Ana, additional, Reisenhofer, Barbara, additional, Boshchenko, Alla, additional, Ryabova, Tamara, additional, Rodriguez-Zanella, Hugo, additional, Rigo, Fausto, additional, D'Andrea, Antonello, additional, Gaibazzi, Nicola, additional, Merli, Elisa, additional, Lisi, Matteo, additional, Simova, Iana, additional, Barbieri, Andrea, additional, Morrone, Doralisa, additional, Pitino, Annalisa, additional, De Nes, Michele, additional, Tripepi, Giovanni L., additional, Yin, Lixue, additional, Citro, Rodolfo, additional, Carerj, Scipione, additional, Pepi, Mauro, additional, Pellikka, Patricia A., additional, and Picano, Eugenio, additional

Published
2024
Full Text
View/download PDF

27. Osteopontin, death and cardiovascular events in stage G3-4 CKD patients: a joint model analysis

Author

D'Arrigo, Graziella, primary, Carbone, Federico, additional, Gori, Mercedes, additional, Montecucco, Fabrizio, additional, Liberale, Luca, additional, Ramoni, Davide, additional, Tirandi, Amedeo, additional, Tortorella, Curzia, additional, Lisa, Anna, additional, Olivero, Chiara, additional, Moriero, Margherita, additional, Bertolotto, Maria, additional, Minetti, Silvia, additional, Schiavetta, Elisa, additional, Pizzini, Patrizia, additional, Cutrupi, Sebastiano, additional, Mallamaci, Francesca, additional, Tripepi, Giovanni, additional, and Zoccali, Carmine, additional

Published
2024
Full Text
View/download PDF

29. Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation

Author

Martino, Massimo, Gori, Mercedes, Porto, Gaetana, Pellicano, Maria, Santoro, Ludovica, Verduci, Chiara, Canale, Filippo Antonio, Loteta, Barbara, Moscato, Tiziana, Alati, Caterina, Ieracitano, Maria Consuelo, Cuzzocrea, Amelia, Altomonte, Maria, Florenzano, Maria Teresa, Morabito, Antonella, Irrera, Giuseppe, Naso, Virginia, Pugliese, Marta, Console, Giuseppe, Ferreri, Anna, Imbalzano, Lucrezia, Tripepi, Giovanni, and Pitino, Annalisa

Published
2023
Full Text
View/download PDF

32. Impact of Serum Phosphate on Hemoglobin Level: A Longitudinal Analysis on a Large Cohort of Dialysis Patients.

Author

Calabrese, Vincenzo, Tripepi, Giovanni Luigi, Santoro, Domenico, Cernaro, Valeria, Panuccio, Vincenzo Antonio, Mezzatesta, Sabrina, Mattace-Raso, Francesco, and Torino, Claudia

Subjects
*FIBROBLAST growth factors, *MEDIAN (Mathematics), *BLOOD serum analysis, *KIDNEY physiology, *HEMODIALYSIS patients
Abstract

Background/Objectives: Phosphate is a macro-element involved in all cellular energetic processes. As about 90% of the phosphate filtered by the glomerulus is excreted by kidneys, the impairment of renal function and the consequent over-secretion of parathyroid hormone and fibroblast growth factor 23 results in the increase in the serum phosphate levels. The association between phosphate and hemoglobin is controversial, as both direct and indirect relationships have been reported. The present study aims to investigate the relationship between phosphate and hemoglobin in a large prospective, longitudinal cohort including dialysis patients from the Sicilian Registry of Nephrology, Dialysis, and Transplantation. Methods: In this prospective cohort study, we included 6263 hemodialysis patients to achieve a total of 120,462 repeated measurements of serum phosphate and hemoglobin over time. The longitudinal association between phosphate and hemoglobin was analyzed by univariate and multivariate Linear Mixed Models. Results: The mean age was 66 ± 16 years and the median dialysis vintage was 5 months [IQR: 2–16]. Mean and median values of hemoglobin and phosphate were 10.7 g/dL (SD 1.3 g/dL) and 4.6 mg/dL [IQR 3.9–5.5 mg/dL], respectively. The multivariate model, adjusted for potential confounders, confirmed the positive association between serum phosphate and hemoglobin [adjβ = 0.13, 95%CI 0.03–0.23, p = 0.01)]. These results were confirmed in analyses stratified for the use of phosphate binders. Conclusions: In our large cohort of dialysis patients, we found a linear, direct relationship between phosphate and hemoglobin levels. As a reduction in phosphate is associated with a parallel reduction in hemoglobin levels, hypophosphatemia can accentuate anemia in dialysis patients. Our results generate the hypothesis that monitoring serum phosphate in clinical practice might provide a better management of anemia. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

33. MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

Author

Nano, Ennio, Reggiani, Francesco, Amaro, Adriana Agnese, Monti, Paola, Colombo, Monica, Bertola, Nadia, Ferrero, Fabiana, Fais, Franco, Bruzzese, Antonella, Martino, Enrica Antonia, Vigna, Ernesto, Puccio, Noemi, Pistoni, Mariaelena, Torricelli, Federica, D'Arrigo, Graziella, Greco, Gianluigi, Tripepi, Giovanni, Adornetto, Carlo, Gentile, Massimo, and Ferrarini, Manlio

Abstract

A "watch and wait" strategy, delaying treatment until active disease manifests, is adopted for most CLL cases; however, prognostic models incorporating biomarkers have shown to be useful to predict treatment requirement. In our prospective O-CLL1 study including 224 patients, we investigated the predictive role of 513 microRNAs (miRNAs) on time to first treatment (TTFT). In the context of this study, six well-established variables (i.e., Rai stage, beta-2-microglobulin levels, IGVH mutational status, del11q, del17p, and NOTCH1 mutations) maintained significant associations with TTFT in a basic multivariable model, collectively yielding a Harrell's C-index of 75% and explaining 45.4% of the variance in the prediction of TTFT. Concerning miRNAs, 73 out of 513 were significantly associated with TTFT in a univariable model; of these, 16 retained an independent relationship with the outcome in a multivariable analysis. For 8 of these (i.e., miR-582-3p, miR-33a-3p, miR-516a-5p, miR-99a-5p, and miR-296-3p, miR-502-5p, miR-625-5p, and miR-29c-3p), a lower expression correlated with a shorter TTFT, whereas in the remaining eight (i.e., miR-150-5p, miR-148a-3p, miR-28-5p, miR-144-5p, miR-671-5p, miR-1-3p, miR-193a-3p, and miR-124-3p), the higher expression was associated with shorter TTFT. Integrating these miRNAs into the basic model significantly enhanced predictive accuracy, raising the Harrell's C-index to 81.1% and the explained variation in TTFT to 63.3%. Moreover, the inclusion of the miRNA scores enhanced the integrated discrimination improvement (IDI) and the net reclassification index (NRI), underscoring the potential of miRNAs to refine CLL prognostic models and providing insights for clinical decision-making. In silico analyses on the differently expressed miRNAs revealed their potential regulatory functions of several pathways, including those involved in the therapeutic responses. To add a biological context to the clinical evidence, an miRNA–mRNA correlation analysis revealed at least one significant negative correlation between 15 of the identified miRNAs and a set of 50 artificial intelligence (AI)-selected genes, previously identified by us as relevant for TTFT prediction in the same cohort of CLL patients. In conclusion, the identification of specific miRNAs as predictors of TTFT holds promise for enhancing risk stratification in CLL to predict therapeutic needs. However, further validation studies and in-depth functional analyses are required to confirm the robustness of these observations and to facilitate their translation into meaningful clinical utility. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity—An Italian Study.

Author

Fusaro, Maria, Aghi, Andrea, Marino, Carmela, Mallamaci, Francesca, Plebani, Mario, Zaninotto, Martina, Grano, Maria, Colucci, Silvia, Gallieni, Maurizio, Nickolas, Thomas L., Giannini, Sandro, Sella, Stefania, Simioni, Paolo, Bazzocchi, Alberto, Guglielmi, Giuseppe, Taddei, Fulvia, Schileo, Enrico, Versace, Maria Carmela, and Tripepi, Giovanni

Subjects
RENAL osteodystrophy, MATRIX Gla protein, VITAMIN K, BONE health, ARTERIAL calcification
Abstract

Background/Objectives: Chronic kidney disease and mineral bone disorders (CKD-MBD) are frequently associated with an increased risk of both vascular calcifications (VCs) and bone fractures (BFs). The complex pathogenesis of VCs and BFs involves various factors such as calcium overload, phosphate imbalance, and secondary hyperparathyroidism. Key players, such as the vitamin K-dependent proteins (VKDPs) matrix Gla protein (MGP) and bone Gla protein (BGP), have pivotal roles both for VCs and BFs. The VIKI study highlighted that hemodialysis patients treated with calcimimetics had higher levels of total BGP and MGP compared to those untreated, suggesting a potential protective effect of these drugs on BFs and VCs beyond the beneficial effect of reducing PTH levels. Methods: ETERNITY-ITA is a multi-center, comparative effectiveness, observational, longitudinal study that will enroll 160 hemodialysis patients (80 patients treated with Etelcalcetide and 80 age- and sex-matched patients treated with calcitriol or vitamin D analogs). Nephrologists will tailor the target dose of Etelcalcetide on an individual level to achieve the KDIGO PTH target. In the Etelcalcetide-treated group, the addition of calcitriol will be allowed when required by clinical practice (for correction of hypocalcemia). Conclusions: This study will evaluate the real-world effect of Etelcalcetide on VKDP levels, such as BGP and MGP, at 3, 9, and 18 months from baseline. The resulting preservation of vascular and bone health will be assessed for the first time by examining aortic and iliac artery calcifications and vertebral fractures, respectively. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Lactoferrin efficacy in treating hyperferritinemia in patients suffering from pathologies unrelated to hereditary hemochromatosis.

Author

Pollio, Giuditta, Rosa, Luigi, Costanzo, Anna Maria, Paesano, Rosalba, Tripepi, Giovanni, and Valenti, Piera

Subjects
IRON in the body, GLOBULAR proteins, BLOOD sedimentation, ERYTHROCYTES, HYPERFERRITINEMIA
Abstract

Ferritin (Ftn), a globular protein, sequesters 4500 atoms of iron per molecule. Elevated serum Ftn levels (hyperferritinemia) is an indicator of iron homeostasis disorders. We present the results of an observational study involving 17 patients with hyperferritinemia unrelated to hereditary hemochromatosis (HH). All participants received treatment with 200 mg of bovine lactoferrin (bLf) once (n = 14) or twice (n = 3) a day before meals. The patients, treated with 200 mg/day of bLf, exhibited a significant increase in red blood cells (+10%, p < 0.001), hemoglobin (+4%, p < 0.001), and hematocrit (+15%, p = 0.004), accompanied by a significant reduction in serum Ftn levels (−52%, p < 0.001), C-reactive protein (CRP) (−85.0%, p < 0.001), and D-dimers (−19%, p < 0.001). Among the three patients treated with 400 mg/day of bLf, two had effects similar to those of patients bLf-treated with 200 mg/day and one experienced a strong reduction of Ftn, CRP, and erythrocyte sedimentation rate (from −97% to −75%). The decrease in serum Ftn levels due to bLf treatment was largely independent of gender (p = 0.78), age (p = 0.66), baseline symptoms (p = 0.20), and concomitant acute (p = 0.34) and chronic (p = 0.53) infections. Although this observational pilot study yields positive effects in patients with hyperferritinemia unrelated to HH treated with bLf, a larger sample size is needed for conclusive results. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

36. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients.

Author

Torino, Claudia, Carbone, Federico, Pizzini, Patrizia, Mezzatesta, Sabrina, D'Arrigo, Graziella, Gori, Mercedes, Liberale, Luca, Moriero, Margherita, Michelauz, Cristina, Frè, Federica, Isoppo, Simone, Gavoci, Aurora, La Rosa, Federica, Scuricini, Alessandro, Tirandi, Amedeo, Ramoni, Davide, Mallamaci, Francesca, Tripepi, Giovanni, Montecucco, Fabrizio, and Zoccali, Carmine

Subjects
BLACK South Africans, LOW density lipoprotein receptors, HEMODIALYSIS patients, SUBTILISINS, REGRESSION analysis
Abstract

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9), a factor accelerating the degradation of LDL receptors, was associated with a gender‐dependent risk for cardiovascular (CV) events in the general population and with all‐cause and CV mortality in two relatively small studies in black Africans and South Korean haemodialysis patients. The effect modification by gender was untested in these studies. Methods: The study enrolled 1188 dialysis patients from the Prospective Registry of The Working Group of Epidemiology of Dialysis Region Calabria (PROGREDIRE) cohort. PCSK9 was measured by colorimetric enzyme‐linked immunosorbent assay. The primary outcomes were all‐cause and CV mortality. Statistical analysis included Cox regression analysis and effect modification analysis. Results: During a median 2.9‐year follow‐up, out of 494 deaths, 278 were CV‐related. In unadjusted analyses, PCSK9 levels correlated with increased all‐cause (HRfor1ln unit increase: 1.23, 95% CI 1.06–1.43, p =.008) and CV mortality (HRfor1ln unit increase: 1.26, 95% CI 1.03–1.54, p =.03). After multivariate adjustment, these associations were no longer significant (all‐cause mortality, HRfor 1 ln unit increase: 1.16, 95% CI.99–1.36, p =.07; CV mortality, HRfor1ln unit increase: 1.18, 95% CI.95–1.46, p =.14). However, in fully adjusted interaction analyses, a doubling in the risk of this outcome in women was registered (Women, HRfor1ln unit increase: 1.88, 95% CI 1.27–2.78, p =.002; Men, HRfor1ln unit increase: 1.07, 95% CI.83–1.38, p =.61; p for effect modification:.02). Conclusions: PCSK9 levels are unrelated to all‐cause mortality in haemodialysis patients but, like in studies of the general population, independently of other risk factors, entail a doubling in the risk of CV events in women in this population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. The Role of Vitamin K in CKD-MBD

Author

Fusaro, Maria, Tondolo, Francesco, Gasperoni, Lorenzo, Tripepi, Giovanni, Plebani, Mario, Zaninotto, Martina, Nickolas, Thomas L., Ketteler, Markus, Aghi, Andrea, Politi, Cristina, La Manna, Gaetano, Brandi, Maria Luisa, Ferrari, Serge, Gallieni, Maurizio, Mereu, Maria Cristina, and Cianciolo, Giuseppe

Published
2022
Full Text
View/download PDF

40. A randomized multicenter trial on a lung ultrasound–guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk

Author

Zoccali, Carmine, Torino, Claudia, Mallamaci, Francesca, Sarafidis, Pantelis, Papagianni, Aikaterini, Ekart, Robert, Hojs, Radovan, Klinger, Marian, Letachowicz, Krzysztof, Fliser, Danilo, Seiler-Mußler, Sarah, Lizzi, Fabio, Wiecek, Andrzej, Miskiewicz, Agata, Siamopoulos, Kostas, Balafa, Olga, Slotki, Itzchak, Shavit, Linda, Stavroulopoulos, Aristeidis, Covic, Adrian, Siriopol, Dimitrie, Massy, Ziad A., Seidowsky, Alexandre, Battaglia, Yuri, Martinez-Castelao, Alberto, Polo-Torcal, Carolina, Coudert-Krier, Marie-Jeanne, Rossignol, Patrick, Fiaccadori, Enrico, Regolisti, Giuseppe, Hannedouche, Thierry, Bachelet, Thomas, Jager, Kitty J., Dekker, Friedo W., Tripepi, Rocco, Tripepi, Giovanni, Gargani, Luna, Sicari, Rosa, Picano, Eugenio, and London, Gérard Michel

Published
2021
Full Text
View/download PDF

41. #2470 Isolated diastolic hypertension in hemodialysis patients

Author

Torino, Claudia, primary, Mallamaci, Francesca, additional, Sarafidis, Pantelis, additional, Ekart, Robert, additional, Balafa, Olga, additional, Del Giudice, Antonio, additional, Aucella, Filippo, additional, Morosetti, Massimo, additional, Tripepi, Rocco, additional, Marino, Carmela, additional, Tripepi, Giovanni Luigi, additional, and Zoccali, Carmine, additional

Published
2024
Full Text
View/download PDF

42. PREVALENCE AND RISK FACTORS OF ALTERED CONTROL OF BP DURING THE NIGHT IN A LARGE HEMODIALYSIS POPULATION INVESTIGATED BY 48 HOURS ABPM

Author

Torino, Claudia, primary, Mallamaci, Francesca, additional, Sarafidis, Pantelis, additional, Papagianni, Aikaterini, additional, Ekart, Robert, additional, Hojs, Radovan, additional, Balafa, Olga, additional, Del Giudice, Antonio, additional, Aucella, Filippo, additional, Morosetti, Massimo, additional, Tripepi, Rocco, additional, Marino, Carmela, additional, Tripepi, Giovanni, additional, and Zoccali, Carmine, additional

Published
2024
Full Text
View/download PDF

43. #2034 CKD-MBD management: results from a national survey on bone turnover biomarkers practice and therapeutic strategies among Italian nephrologists

Author

Fusaro, Maria, primary, Sartò, Giulia Vanessa Re, additional, Gallieni, Maurizio, additional, Bianchi, Stefano, additional, De Nicola, Luca, additional, Plebani, Mario, additional, Zaninotto, Martina, additional, Cossettini, Althea, additional, Cosmai, Laura, additional, Marino, Carmela, additional, Aghi, Andrea, additional, and Tripepi, Giovanni Luigi, additional

Published
2024
Full Text
View/download PDF

45. #2990 Prevalence and risk factors of altered control of BP during the night in a large hemodialysis population investigated by 48 hours ABPM

Author

Torino, Claudia, primary, Mallamaci, Francesca, additional, Sarafidis, Pantelis, additional, Ekart, Robert, additional, Balafa, Olga, additional, Del Giudice, Antonio, additional, Aucella, Filippo, additional, Morosetti, Massimo, additional, Tripepi, Rocco, additional, Marino, Carmela, additional, Tripepi, Giovanni Luigi, additional, and Zoccali, Carmine, additional

Published
2024
Full Text
View/download PDF

46. POOR TOLERABILITY OF THE STANDARD, EXTENDED, 48H AMBULATORY BLOOD PRESSURE MONITORING IN HEMODIALYSIS PATIENTS

Author

Torino, Claudia, primary, Mallamaci, Francesca, additional, Sarafidis, Pantelis, additional, Papagianni, Aikaterini, additional, Ekart, Robert, additional, Hojs, Radovan, additional, Balafa, Olga, additional, Giudice, Antonio Del, additional, Aucella, Filippo, additional, Morosetti, Massimo, additional, Tripepi, Rocco, additional, Marino, Carmela, additional, Tripepi, Giovanni, additional, and Zoccali, Carmine, additional

Published
2024
Full Text
View/download PDF

48. Biomarkers in clinical epidemiology studies

Author

Zoccali, Carmine, primary, Tripepi, Giovanni, additional, Stel, Vianda, additional, Fu, Eduard L, additional, Mallamaci, Francesca, additional, Dekker, Friedo, additional, and Jager, Kitty J, additional

Published
2024
Full Text
View/download PDF

49. Effects of working from home on lifestyle behaviors and mental health during the COVID-19 pandemic: A survey study

Author

Scoditti, Egeria, primary, Bodini, Antonella, additional, Sabina, Saverio, additional, Leo, Carlo Giacomo, additional, Mincarone, Pierpaolo, additional, Rissotto, Antonella, additional, Fusco, Stanislao, additional, Guarino, Roberto, additional, Ponzini, Giuseppe, additional, Tumolo, Maria Rosaria, additional, Magnavita, Nicola, additional, Tripepi, Giovanni Luigi, additional, and Garbarino, Sergio, additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results